Down-regulation of mannose receptor activity in macrophages after treatment with lipopolysaccharide and phorbol

V L Shepherd1, R Abdolrasulnia, M Garrett

  • 1VA Medical Center, Nashville, TN 37212.

Insights

Lipopolysaccharide (LPS) and phorbol 12-myristate 13-acetate (PMA) significantly reduce functional mannose receptor activity in macrophages by causing inactivation, not affecting synthesis or turnover. Dexamethasone prevents this down-regulation.

Area of Science:

  • Immunology
  • Cell Biology
  • Macrophage Biology

Background:

  • Mannose receptors are crucial for innate immunity and phagocytosis in macrophages.
  • Understanding how external stimuli affect mannose receptor function is vital for immune response modulation.

Purpose of the Study:

  • To investigate the impact of lipopolysaccharide (LPS) and phorbol 12-myristate 13-acetate (PMA) on functional mannose receptor expression in rat bone marrow-derived macrophages.
  • To elucidate the mechanisms underlying LPS/PMA-induced changes in mannose receptor activity.

Main Methods:

  • Treatment of macrophages with LPS and PMA.
  • Assay of mannose receptor activity and ligand uptake.
  • Analysis of receptor synthesis, turnover, and binding kinetics.
  • Investigation of the role of dexamethasone and serine protease inhibitors.

Main Results:

  • LPS and PMA treatment reduced mannose receptor activity by 70-80% through inactivation, not affecting receptor biosynthesis or turnover.
  • Dexamethasone pretreatment blocked the LPS/PMA-induced down-regulation.
  • Ligand uptake capacity decreased by 80% without altering the uptake constant (Kuptake).
  • Total binding sites (intracellular and surface) were reduced to approximately 30%.

Conclusions:

  • LPS/PMA treatment leads to functional inactivation of mannose receptors in macrophages.
  • The down-regulation mechanism involves inactivation rather than changes in receptor synthesis or degradation.
  • Dexamethasone can protect mannose receptors from LPS/PMA-induced inactivation.